Drawing for CLAROS

USPTO serial 99037129

CLAROS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HOPKINS, SARAH COLLEEN
Law office
TMO LAW OFFICE 123

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CLAROS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jill Anderfuren

Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP550 West Adams StreetSuite 300Chicago, IL 60661

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents and assays for testing of body fluids; medical diagnostic test media in the form of cassettes or cards for testing of blood for abnormalities, diseases, urogenital system diseases, cancer, androgen-related conditions, and vitamin D insufficiency; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic cards containing medical diagnostic reagents and immunoassays for testing body fluids for the purpose of diagnosing and monitoring urogenital system diseases, cancer, androgen-related conditions, and vitamin D insufficiencyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 9, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 9, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 26, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 23, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 23, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Oct 23, 2025CNSLSUSPENSION LETTER WRITTEN—
Oct 22, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2025DOCKASSIGNED TO EXAMINER—
Feb 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 11, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance